113 related articles for article (PubMed ID: 21569259)
1. FTLD-TDP with motor neuron disease, visuospatial impairment and a progressive supranuclear palsy-like syndrome: broadening the clinical phenotype of TDP-43 proteinopathies. A report of three cases.
Rusina R; Kovacs GG; Fiala J; Hort J; Ridzoň P; Holmerová I; Ströbel T; Matěj R
BMC Neurol; 2011 May; 11():50. PubMed ID: 21569259
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological correlations in behavioural variant frontotemporal dementia.
Perry DC; Brown JA; Possin KL; Datta S; Trujillo A; Radke A; Karydas A; Kornak J; Sias AC; Rabinovici GD; Gorno-Tempini ML; Boxer AL; De May M; Rankin KP; Sturm VE; Lee SE; Matthews BR; Kao AW; Vossel KA; Tartaglia MC; Miller ZA; Seo SW; Sidhu M; Gaus SE; Nana AL; Vargas JNS; Hwang JL; Ossenkoppele R; Brown AB; Huang EJ; Coppola G; Rosen HJ; Geschwind D; Trojanowski JQ; Grinberg LT; Kramer JH; Miller BL; Seeley WW
Brain; 2017 Dec; 140(12):3329-3345. PubMed ID: 29053860
[TBL] [Abstract][Full Text] [Related]
3. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418
[TBL] [Abstract][Full Text] [Related]
4. Neuropathological heterogeneity in frontotemporal lobar degeneration with TDP-43 proteinopathy: a quantitative study of 94 cases using principal components analysis.
Armstrong RA; Ellis W; Hamilton RL; Mackenzie IR; Hedreen J; Gearing M; Montine T; Vonsattel JP; Head E; Lieberman AP; Cairns NJ
J Neural Transm (Vienna); 2010 Feb; 117(2):227-39. PubMed ID: 20012109
[TBL] [Abstract][Full Text] [Related]
5. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration.
Cairns NJ; Bigio EH; Mackenzie IR; Neumann M; Lee VM; Hatanpaa KJ; White CL; Schneider JA; Grinberg LT; Halliday G; Duyckaerts C; Lowe JS; Holm IE; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson DW; Ince PG; Trojanowski JQ; Mann DM;
Acta Neuropathol; 2007 Jul; 114(1):5-22. PubMed ID: 17579875
[TBL] [Abstract][Full Text] [Related]
6. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.
Rabinovici GD; Miller BL
CNS Drugs; 2010 May; 24(5):375-98. PubMed ID: 20369906
[TBL] [Abstract][Full Text] [Related]
7. TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43.
Godoy-Corchuelo JM; Ali Z; Brito Armas JM; Martins-Bach AB; García-Toledo I; Fernández-Beltrán LC; López-Carbonero JI; Bascuñana P; Spring S; Jimenez-Coca I; Muñoz de Bustillo Alfaro RA; Sánchez-Barrena MJ; Nair RR; Nieman BJ; Lerch JP; Miller KL; Ozdinler HP; Fisher EMC; Cunningham TJ; Acevedo-Arozena A; Corrochano S
Neurobiol Dis; 2024 Apr; 193():106437. PubMed ID: 38367882
[TBL] [Abstract][Full Text] [Related]
8. Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes.
Murley AG; Coyle-Gilchrist I; Rouse MA; Jones PS; Li W; Wiggins J; Lansdall C; Rodríguez PV; Wilcox A; Tsvetanov KA; Patterson K; Lambon Ralph MA; Rowe JB
Brain; 2020 May; 143(5):1555-1571. PubMed ID: 32438414
[TBL] [Abstract][Full Text] [Related]
9. Odor identification in frontotemporal lobar degeneration subtypes.
Magerova H; Vyhnalek M; Laczo J; Andel R; Rektorova I; Kadlecova A; Bojar M; Hort J
Am J Alzheimers Dis Other Demen; 2014 Dec; 29(8):762-8. PubMed ID: 24939002
[TBL] [Abstract][Full Text] [Related]
10. GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition.
Murley AG; Rouse MA; Jones PS; Ye R; Hezemans FH; O'Callaghan C; Frangou P; Kourtzi Z; Rua C; Carpenter TA; Rodgers CT; Rowe JB
Brain; 2020 Dec; 143(11):3449-3462. PubMed ID: 33141154
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological correlates in frontotemporal lobar degeneration: motor neuron disease spectrum.
Carbayo Á; Borrego-Écija S; Turon-Sans J; Cortés-Vicente E; Molina-Porcel L; Gascón-Bayarri J; Rubio MÁ; Povedano M; Gámez J; Sotoca J; Juntas-Morales R; Almendrote M; Marquié M; Sánchez-Valle R; Illán-Gala I; Dols-Icardo O; Rubio-Guerra S; Bernal S; Caballero-Ávila M; Vesperinas A; Gelpi E; Rojas-García R
Brain; 2024 Jan; ():. PubMed ID: 38227807
[TBL] [Abstract][Full Text] [Related]
12. Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome.
Aiba I; Hayashi Y; Shimohata T; Yoshida M; Saito Y; Wakabayashi K; Komori T; Hasegawa M; Ikeuchi T; Tokumaru AM; Sakurai K; Murayama S; Hasegawa K; Uchihara T; Toyoshima Y; Saito Y; Yabe I; Tanikawa S; Sugaya K; Hayashi K; Sano T; Takao M; Sakai M; Fujimura H; Takigawa H; Adachi T; Hanajima R; Yokota O; Miki T; Iwasaki Y; Kobayashi M; Arai N; Ohkubo T; Yokota T; Mori K; Ito M; Ishida C; Tanaka M; Idezuka J; Kanazawa M; Aoki K; Aoki M; Hasegawa T; Watanabe H; Hashizume A; Niwa H; Yasui K; Ito K; Washimi Y; Mukai E; Kubota A; Toda T; Nakashima K;
Brain Commun; 2023; 5(6):fcad296. PubMed ID: 38090279
[TBL] [Abstract][Full Text] [Related]
13. Predictors of survival in frontotemporal lobar degeneration syndromes.
El-Wahsh S; Finger EC; Piguet O; Mok V; Rohrer JD; Kiernan MC; Ahmed RM
J Neurol Neurosurg Psychiatry; 2021 Jan; ():. PubMed ID: 33441385
[TBL] [Abstract][Full Text] [Related]
14. An autopsy case of type A FTLD-TDP with a GRN mutation presenting with the logopenic variant of primary progressive aphasia at onset and with corticobasal syndrome subsequently.
Tomenaga T; Minatani S; Namba H; Takeda A; Yoshizaki T; Kawabe J; Keyoumu N; Morino H; Higuchi M; Matsubara T; Hatsuta H; Hasegawa M; Murayama S; Itoh Y
Neuropathology; 2024 May; ():. PubMed ID: 38715398
[TBL] [Abstract][Full Text] [Related]
15. Neurotransmitter deficits from frontotemporal lobar degeneration.
Murley AG; Rowe JB
Brain; 2018 May; 141(5):1263-1285. PubMed ID: 29373632
[TBL] [Abstract][Full Text] [Related]
16. Time to Diagnosis and Its Predictors in Syndromes Associated With Frontotemporal Lobar Degeneration.
Libri I; Altomare D; Bracca V; Rivolta J; Cantoni V; Mattioli I; Alberici A; Borroni B
Am J Geriatr Psychiatry; 2024 Mar; ():. PubMed ID: 38521735
[TBL] [Abstract][Full Text] [Related]
17. Retrospective neuropathological diagnosis of TDP-43 proteinopathies: Factors affecting immunoreactivity of phosphorylated TDP-43 in fixed post-mortem brain tissue.
Robinson AC; Davidson YS; Minshull J; Lally I; Walker L; Mann DMA; Roncaroli F
Neuropathology; 2024 Apr; 44(2):173-179. PubMed ID: 37528690
[No Abstract] [Full Text] [Related]
18. Sporadic fatal insomnia: a rapidly progressive phenotype resembling progressive supranuclear palsy.
Romero-Fábrega JC; Lorenzo-López R; Rivas-Infante E; Escamilla-Sevilla F; Rashki M; Mínguez-Castellanos A; Carvajal-Hernández A
Neurologia (Engl Ed); 2024 Feb; ():. PubMed ID: 38387778
[No Abstract] [Full Text] [Related]
19. Author Correction: Female sex mitigates motor and behavioural phenotypes in TDP-43
Watkins J; Ghosh A; Keerie AFA; Alix JJP; Mead RJ; Sreedharan J
Sci Rep; 2021 May; 11(1):11058. PubMed ID: 34017015
[No Abstract] [Full Text] [Related]
20. A case of familial frontotemporal dementia caused by a progranulin gene mutation.
Currens L; Harrison N; Schmidt M; Amjad H; Mu W; Scholz SW; Bang J; Pantelyat A
Clin Park Relat Disord; 2023; 9():100213. PubMed ID: 37583427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
